Compile Data Set for Download or QSAR
maximum 50k data
Found 247 Enz. Inhib. hit(s) with all data for entry = 8655
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM56256(MLS000110334 | N-(3-carbazol-9-yl-2-hydroxy-propyl...)
Affinity DataEC50:  340nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140703(CHEMBL3754134 | US10383880, Example 2)
Affinity DataEC50:  742nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140702(CHEMBL3753702 | US10383880, Example 3)
Affinity DataEC50:  650nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140895(CHEMBL3753417 | US10383880, Example 4)
Affinity DataEC50:  2.50E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410791(US10383880, Example 5)
Affinity DataEC50:  8.19E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410792(US10383880, Example 6)
Affinity DataEC50:  964nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410793(US10383880, Example 7)
Affinity DataEC50:  2.11E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410794(US10383880, Example 8)
Affinity DataEC50:  6.96E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410795(US10383880, Example 9)
Affinity DataEC50:  2.86E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410796(US10383880, Example 10)
Affinity DataEC50:  1.13E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140693(CHEMBL3753394 | US10383880, Example 11)
Affinity DataEC50:  1.79E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410798(US10383880, Example 12)
Affinity DataEC50:  1.01E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140698(CHEMBL3753223 | US10383880, Example 13)
Affinity DataEC50:  454nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140896(CHEMBL3752727 | US10383880, Example 14)
Affinity DataEC50:  652nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410802(US10383880, Example 15)
Affinity DataEC50:  592nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140696(CHEMBL3752613 | US10383880, Example 16)
Affinity DataEC50:  1.67E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410805(US10383880, Example 17)
Affinity DataEC50:  2.49E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410806(US10383880, Example 18)
Affinity DataEC50:  3.77E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410807(US10383880, Example 19)
Affinity DataEC50:  2.10E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140888(CHEMBL3753839 | US10383880, Example 20)
Affinity DataEC50:  29nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410809(US10383880, Example 21)
Affinity DataEC50:  440nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140765(CHEMBL1446115 | US10383880, Example 23)
Affinity DataEC50:  510nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140765(CHEMBL1446115 | US10383880, Example 23)
Affinity DataEC50:  90nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140885(CHEMBL3752453 | US10383880, Example 24)
Affinity DataEC50:  210nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410813(US10383880, Example 25)
Affinity DataEC50:  170nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410814(US10383880, Example 26)
Affinity DataEC50:  1.30E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410815(US10383880, Example 27)
Affinity DataEC50:  250nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410816(US10383880, Example 28)
Affinity DataEC50:  2.09E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410817(US10383880, Example 29)
Affinity DataEC50:  710nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140915(CHEMBL3754372 | US10383880, Example 45)
Affinity DataEC50:  390nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410819(US10383880, Example 31)
Affinity DataEC50:  1.40E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140907(CHEMBL1487843 | US10383880, Example 32)
Affinity DataEC50:  100nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140889(CHEMBL3752502 | US10383880, Example 33)
Affinity DataEC50:  35nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410822(US10383880, Example 34)
Affinity DataEC50:  31nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410823(US10383880, Example 35)
Affinity DataEC50:  1.50E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410824(US10383880, Example 36)
Affinity DataEC50:  539nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410825(US10383880, Example 37)
Affinity DataEC50:  34nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410826(US10383880, Example 38)
Affinity DataEC50:  11nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410827(US10383880, Example 39)
Affinity DataEC50:  21nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410828(US10383880, Example 40)
Affinity DataEC50:  179nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410829(US10383880, Example 41)
Affinity DataEC50:  343nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410830(US10383880, Example 43)
Affinity DataEC50:  3.00E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140886(CHEMBL3753460 | US10383880, Example 44)
Affinity DataEC50:  8.27E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140915(CHEMBL3754372 | US10383880, Example 45)
Affinity DataEC50:  398nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140919(CHEMBL3753078 | US10383880, Example 46)
Affinity DataEC50:  100nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410834(US10383880, Example 47)
Affinity DataEC50:  3.36E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410835(US10383880, Example 48)
Affinity DataEC50:  1.50E+3nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM50140920(CHEMBL3752323 | US10383880, Example 49)
Affinity DataEC50:  100nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410837(US10383880, Example 50)
Affinity DataEC50:  148nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeriod circadian protein homolog 2(Homo sapiens (Human))
Synchronicity

US Patent
LigandPNGBDBM410838(US10383880, Example 51)
Affinity DataEC50:  371nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 247 total ) | Next | Last >>
Jump to: